Focus: Find Therapeutics is a Series A-stage biotech company focused on developing GPCR-targeting therapeutics for neurology and metabolic diseases. Based in Saint-Laurent, Quebec, the company is in early clinical development with a lean operational footprint.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Hot — 31 jobs added in 30d
Net +30 (31 new, 1 removed). Aggressive expansion phase.
Best suited for risk-tolerant early-stage operators seeking equity upside and learning in a focused GPCR-biology platform; avoid if you need financial transparency or near-term clinical milestones.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Find Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Find Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles